ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells (Q28236488)
Jump to navigation
Jump to search
scientific article (publication date: 14 September 2006)
Language | Label | Description | Also known as |
---|---|---|---|
English | ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells |
scientific article (publication date: 14 September 2006) |
Statements
ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells (English)
0 references
14 September 2006
0 references
25
0 references
5591-600
0 references
41
0 references
1 reference